These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 1577392

  • 21. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD, Carvalho EB, Franco JD, Soares MP, Brito EM, Belarmino K, Coelho LG.
    Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
    [Abstract] [Full Text] [Related]

  • 22. Powerful gastric acid inhibition: when is it justified?
    Dobrilla G, Amplatz S.
    Ital J Gastroenterol; 1990; 22 Suppl 1():13-7. PubMed ID: 1983420
    [Abstract] [Full Text] [Related]

  • 23. Selection of patients for successful maintenance treatment of esophagitis with low-dose omeprazole: use of 24-hour gastric pH monitoring.
    Ladas SD, Tassios PS, Raptis SA.
    Am J Gastroenterol; 2000 Feb; 95(2):374-80. PubMed ID: 10685738
    [Abstract] [Full Text] [Related]

  • 24. Famotidine in gastroesophageal reflux disease (GERD).
    Wesdorp IC.
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():24-6. PubMed ID: 1577391
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Clinical experience with omeprazole: assessment of efficacy and safety.
    Walan A.
    J Gastroenterol Hepatol; 1989 Feb; 4 Suppl 2():27-33. PubMed ID: 2491359
    [Abstract] [Full Text] [Related]

  • 27. [Long-term course of reflux symptoms following Helicobacter pylori eradication].
    Peitz U, Raps S, Plein K, Leodolter A, Hotz Dagger J, Malfertheiner P.
    Dtsch Med Wochenschr; 2004 Mar 26; 129(13):671-5. PubMed ID: 15026962
    [Abstract] [Full Text] [Related]

  • 28. Clinical utility and safety of omeprazole.
    Walan A.
    Methods Find Exp Clin Pharmacol; 1989 Mar 26; 11 Suppl 1():107-11. PubMed ID: 2657279
    [Abstract] [Full Text] [Related]

  • 29. Treatment of reflux oesophagitis resistant to H2-receptor antagonists.
    Klinkenberg-Knol EC, Meuwissen SG.
    Digestion; 1989 Mar 26; 44 Suppl 1():47-53. PubMed ID: 2575061
    [Abstract] [Full Text] [Related]

  • 30. Medical treatment of gastroesophageal reflux disease: options and priorities.
    Thomson AB.
    Hepatogastroenterology; 1992 Feb 26; 39 Suppl 1():14-23. PubMed ID: 1349550
    [Abstract] [Full Text] [Related]

  • 31. Use of omeprazole in the management of reflux oesophagitis resistant to H2-receptor antagonists.
    Klinkenberg-Knol EC, Jansen JB, Lamers CB, Nelis F, Snel P, Meuwissen SG.
    Scand J Gastroenterol Suppl; 1989 Feb 26; 166():88-93; discussion 94. PubMed ID: 2574911
    [Abstract] [Full Text] [Related]

  • 32. [Long-term results of conservative management of reflux esophagitis].
    Viani F, Dorta G.
    Ther Umsch; 2001 Mar 26; 58(3):146-50. PubMed ID: 11305152
    [Abstract] [Full Text] [Related]

  • 33. [Omeprazole and maintenance treatment: new concepts for traditional therapies?].
    Díaz de Rojas F, Ponce García J.
    An Med Interna; 1992 Sep 26; 9(9):450-4. PubMed ID: 1391583
    [Abstract] [Full Text] [Related]

  • 34. A review of omeprazole use in the treatment of acid-related disorders in children.
    Zimmermann AE, Walters JK, Katona BG, Souney PE, Levine D.
    Clin Ther; 2001 May 26; 23(5):660-79; discussion 645. PubMed ID: 11394727
    [Abstract] [Full Text] [Related]

  • 35. Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.
    Collen MJ, Strong RM.
    Dig Dis Sci; 1992 Jun 26; 37(6):897-903. PubMed ID: 1587194
    [Abstract] [Full Text] [Related]

  • 36. Combined use of omeprazole and a novel antioxidative cytoprotectant for the treatment of peptic ulcer. Facilitation of ulcer healing in experimental animals.
    Kim JM, Choi SM, Kim DH, Oh TY, Ahn BO, Kwon JW, Kim WB.
    Arzneimittelforschung; 2005 Jun 26; 55(7):387-93. PubMed ID: 16080278
    [Abstract] [Full Text] [Related]

  • 37. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
    McTavish D, Buckley MM, Heel RC.
    Drugs; 1991 Jul 26; 42(1):138-70. PubMed ID: 1718683
    [Abstract] [Full Text] [Related]

  • 38. Omeprazole in the short-term treatment of reflux oesophagitis.
    Jansen JB, Lamers CB.
    Digestion; 1989 Jul 26; 44 Suppl 1():40-6. PubMed ID: 2691310
    [Abstract] [Full Text] [Related]

  • 39. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.
    Klinkenberg-Knol EC, Festen HP, Jansen JB, Lamers CB, Nelis F, Snel P, Lückers A, Dekkers CP, Havu N, Meuwissen SG.
    Ann Intern Med; 1994 Aug 01; 121(3):161-7. PubMed ID: 8017742
    [Abstract] [Full Text] [Related]

  • 40. Current trends in the pharmacotherapy for gastroesophageal reflux disease.
    Hixson LJ, Kelley CL, Jones WN, Tuohy CD.
    Arch Intern Med; 1992 Apr 01; 152(4):717-23. PubMed ID: 1558428
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.